Darbepoetin Alfa: A Solution for Dialysis Patients Resistant to EPO

H2 tag- SEO Purpose

EPO: erythropoietin.

Cresp logo
Conversion from high dose EPO to Darbepoetin Alfa

Conversion from high dose EPO to Darbepoetin Alfa proved successful even in dialysis patients resistant to EPO

A multicenter, retrospective cohort study was conducted to evaluate anemia management using Darbepoetin Alfa in dialysis patients.

results

EPO-Resistant Patients:

78.6% of EPO resistant patients


78.6% of EPO resistant patients responded to Darbepoetin Alfa

impact on responsiveness to Darbepoetin Alfa


Age, duration on dialysis and baseline PTH level had no impact on responsiveness to Darbepoetin Alfa

Conclusion